Epigenome.Ai Fundamental Research Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 04-01-2025
- Paid Up Capital ₹ 10.00 Cr
as on 04-01-2025
- Company Age 1 Year 4 Months
- Last Filing with ROC 31 Mar 2024
About Epigenome.Ai Fundamental Research
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Epigenome.Ai Fundamental Research Private Limited India is Hiral Kala as COMPANY SECRETARY. Chetan Singhal, Subodh Yadav, and Siddhartha Das serve as directors at the Company.
- CIN/LLPIN
U62099HR2023PTC114068
- Company No.
114068
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Epigenome.Ai Fundamental Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hiral Kala | Company Secretary | 01-Oct-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subodh Yadav  | Director | 09-Jul-2024 | Current |
| Siddhartha Das | Director | 10-Aug-2023 | Current |
| Chetan Singhal | Director | 10-Aug-2023 | Current |
Financial Performance of Epigenome.Ai Fundamental Research.
Enhance accessibility to Epigenome.Ai Fundamental Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Epigenome.Ai Fundamental Research?
Unlock access to Epigenome.Ai Fundamental Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Infraprime Logistics Technologies Private LimitedActive 7 years 8 monthsChetan Singhal and Subodh Yadav are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Epigenome.Ai Fundamental Research?
Unlock and access historical data on people associated with Epigenome.Ai Fundamental Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Epigenome.Ai Fundamental Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epigenome.Ai Fundamental Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.